Back to Search
THOMAS WHITESIDE, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1457324055IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
E2371(AR)
CMS Specialties
PrimaryPATHOLOGY
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 1996
Research & Publications (20)
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
PMID 19038780·Clin Vaccine Immunol·2009
8-other
The role of death receptor ligands in shaping tumor microenvironment.
PMID 17190648·Immunol Invest·2007
6-review
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
PMID 16153857·Semin Cancer Biol·2006
6-review
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
PMID 15265880·J Immunol·2004
8-other
Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?
PMID 15118842·Cancer Immunol Immunother·2004
6-review
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.
PMID 12080146·Proc Natl Acad Sci U S A·2002
8-other
Tumor-induced death of immune cells: its mechanisms and consequences.
PMID 11926411·Semin Cancer Biol·2002
6-review
Immunobiology and immunotherapy of head and neck cancer.
PMID 11123869·Curr Oncol Rep·2001
4-observational
Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.
PMID 10799441·Clin Diagn Lab Immunol·2000
6-review
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
PMID 19526239·Cancer Immunol Immunother·2010
8-other
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancer.
PMID 19307994·J Immunother·2009
3-trial
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.
PMID 19640287·J Transl Med·2009
3-trial
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
PMID 19417016·Clin Cancer Res·2009
8-other
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.
PMID 19450601·J Immunol Methods·2009
8-other
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
PMID 19318560·Cancer Res·2009
8-other
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
PMID 19543393·PLoS One·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 390 E LONGVIEW ST
FAYETTEVILLE, AR 72703 - Phone
- (479) 442-0144
Quick Facts
- NPI
- 1457324055
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile